Copyright
©The Author(s) 2016.
World J Transplant. Mar 24, 2016; 6(1): 155-164
Published online Mar 24, 2016. doi: 10.5500/wjt.v6.i1.155
Published online Mar 24, 2016. doi: 10.5500/wjt.v6.i1.155
Table 1 The Surfactant system and its relation to risk factors for bronchiolitis obliterans syndrome
BOS risk factor | Effect on surfactant system |
Primary graft dysfunction | Successful treatment with surfactant |
Acute rejection | Type II pneumocyte destruction and surfactant disruption |
Rejection is associated with surfactant dysfunction | |
Immunosuppression preserves Surfactant function | |
GERD - aspiration | Inactivation of surfactant |
Pulmonary infection | Inactivation of surfactant |
Table 2 Hypothetical donor offers for a subject with idiopathic pulmonary fibrosis listed for lung transplantation
Listed subject with IPF | Donor listing | Offer A | Offer B | Offer C | |
Age (yr) | 55 | 12-60 | 42 | 45 | 42 |
Gender | Male | Either | Female | Male | Female |
Height (cm) | 170 | 147-170 | 147 | 170 | 175 |
pTLC (L) | 6.54 | 3.98-6.54 | 3.98 | 6.54 | 5.76 |
pTLCratio | 0.61 | 1.00 | 0.88 |
- Citation: Eberlein M, Reed RM. Donor to recipient sizing in thoracic organ transplantation. World J Transplant 2016; 6(1): 155-164
- URL: https://www.wjgnet.com/2220-3230/full/v6/i1/155.htm
- DOI: https://dx.doi.org/10.5500/wjt.v6.i1.155